10X Genomics (NasdaqGS:TXG) Q3 2025 Earnings Call November 06, 2025 04:30 PM ET Speaker0Thank you for standing by. Welcome to the 10x Genomics Q3 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press the star followed by the number one on your telephone keypad. If you would like to withdraw your question, please press the st ...

PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025. Accessibility StatementSkip Navigation 10x Genomics expects fourth quarter 2025 revenue to be in the range of $154 million to $158 million, representing a 6% decline from the corresponding prior year period and 5% growth sequentially at the midpoint. Recent Updates "Our team delivered a solid third qu ...